GlobeNewswire

Intrinsyc Technologies (TSX: ITC and OTC: ISYRF) debuts system on module and development kit powered by NXP i.MX 8M processor

Dela

Powerful Embedded Computing Solutions Optimized for Multimedia Applications

VANCOUVER, British Columbia, Feb. 22, 2018 (GLOBE NEWSWIRE) -- Intrinsyc Technologies Corporation (TSX:ITC) (OTC:ISYRF) ("Intrinsyc" or the "Company"), a leading provider of solutions for the development and production of embedded and Internet of Things ("IoT") products, today announced the availability of the Open-X(TM) 8M System on Module ("SOM") and Development Kit

Intrinsyc's Open-X(TM) 8M SOM incorporates the new 64-bit NXP i.MX 8M processor and is ideal for powering IoT devices ranging from consumer smart home appliances to industrial building automation products. Its ultra-compact (55mm x 35mm) size enables its use in a wide range of form factors. The feature-rich SOM, with its advanced video and audio features, is ideal for streaming video/audio devices, voice control applications, and human-machine interface solutions. It offers high quality video playback with full 4K UHD and HDR along with the highest level of pro-audio fidelity. The broad range of interfaces, including HDMI 2.0a, two USB 3.0, one PCIe, Gigabit Ethernet, and pre-certified dual-band 2x2 MU-MIMO WLAN make the SOM suitable for a wide range of embedded and IoT products. 

"We are excited to expand our portfolio of embedded SOM solutions with the newly launched NXP i.MX 8M processor," stated Cliff Morton, Vice President, Client Solutions, Intrinsyc Technologies Corporation.  "Intrinsyc's Open-X(TM) SOMs provide a flexible way to rapidly bring IoT devices to market with reduced risk; combining the time-to-market benefits of an off-the-shelf product, with the flexibility and optimization of a custom design. Our latest System on Module, the Open-X(TM) 8M, is ready for production use and will expand opportunities in a variety of multimedia capable embedded and IoT products." 

"Intrinsyc has a long history of providing exceptional product development services for embedded and IoT devices," stated Robert Thompson, i.MX Ecosystem Manager at NXP Semiconductors, N.V.  "We are pleased to see the launch of Intrinsyc's production-ready SOM and development kit powered by the i.MX 8M processor. Intrinsyc's strong product development and technical support capabilities, coupled with a production-ready i.MX 8M powered SOM will help companies rapidly develop their multimedia capable products."

Open-X(TM) 8M SOM Specifications

Processors

  • Quad-core ARM Cortex-A53 MPCore platform
    • Quad symmetric Cortex-A53 processors: 32 KB L1 Instruction Cache, 32 KB L1 Data Cache
    • Support of 64-bit ARMv8-A architecture: 1 MB unified L2 cache, Frequency of 1.5 GHz
  • ARM Cortex-M4 core platform
    • 16 KB L1 Instruction Cache, 16 KB L1 Data Cache, 256 KB tightly coupled memory (TCM)

Memory/Storage

  • 3GB LPDDR4 RAM, 16GB eMMC Flash

Wireless Module - FCC/IC pre-certified

  • WLAN 802.11a/b/g/n/ac 2.4/5.0 GHz 2x2 MU-MIMO
  • Bluetooth 4.1

Display Interfaces

  • HDMI 2.0a supporting resolution up to 4096 x 2160 at 60 Hz
  • 4-lane MIPI DSI supporting display resolution up to 1920x1080 at 60 Hz

Camera Interface

  • 2x 4-lane MIPI CSI2 camera inputs

Video

  • 4Kp60 HEVC/H.265 main, and main 10 decoder
  • 4Kp60 VP9 decoder
  • 4Kp30 AVC/H.264 decoder
  • 1080p60 MPEG-2, MPEG-4p2, VC-1, VP8, RV9, AVS, MJPEG, H.263 decoder

Graphics

  • 4 shader
  • 267 million triangles/sec
  • 1.6 Giga pixel/sec
  • 32 GFLOPs 32-bit or 64 GFLOPs 16-bit
  • Supports OpenGL ES 1.1, 2.0, 3.0, 3.1, Open CL 1.2, and Vulkan

Audio

  • S/PDIF input and output
  • 1x 16 channel bi-directional SAI digital audio interface (I2S, AC97, TDM, DSP)
  • 1x 8 channel receive SAI digital audio interface (I2S, AC97, TDM, DSP)
  • 2x 2 channel bi-directional SAI digital audio interface (I2S, AC97, TDM, DSP)

I/O

  • 2x USB 3.0, 1x PCIe Gen2, Gigabit Ethernet, 4-bit SDIO, 2x debug UART, JTAG

OS Support

  • Linux & Android 8

Operating Environment

  • Input power: 3.3V
  • Operating Temperature: 0°C to +70°C

Additional information is available at: https://www.intrinsyc.com/imx-embedded-development-kits/open-x-8m-development-kit/

To enable rapid development of devices using the Open-X(TM) 8M SOM, Intrinsyc offers the Open-X(TM) 8M Development Kit; a full-featured development platform including the software tools and accessories required to immediately begin development. 

Intrinsyc's Open-X(TM) 8M Development Kit is a cost-effective, feature rich, multimedia-focused, exposed board platform powered by our Open-X(TM) 8M System on Module (SOM). It is ideal for evaluation of the Open-X(TM) 8M SOM as well as jump-starting development of streaming video/audio devices, voice control and general human-machine interface solutions. HDMI 2.0a video output is provided for ease of use out of the box, and our optional LCD/touchpanel is also compatible. With a multitude of high performance interconnect options, including two USB3.0 ports, Gigabit Ethernet, PCIe Gen2, and pre-certified dual-band 2x2 MU-MIMO WLAN, this platform is ideal for development of a wide range of multimedia capable embedded and IoT applications.  

In support of new product designs based on the Open-X(TM) 8M SOM, Intrinsyc offers a robust board support package, advanced technical support and comprehensive product development services including; rapid prototyping, mechanical and electrical design, BSP and driver development, and middleware and application development.  Contact Intrinsyc at sales@Intrinsyc.com with your product requirements and have one of the Company's solution architects help plan for your successful product development and launch.

Intrinsyc will showcase the Open-X(TM) 8M SOM and Development Kit at Embedded World 2018, Nuremberg Exhibition Centre Booth 4A-425, Nuremberg, Germany, from 27 February to 1 March.

About Intrinsyc Technologies Corporation
Intrinsyc Technologies Corporation is a product development company that provides hardware, software, and engineering and production services that enable rapid commercialization of embedded and Internet of Things (IoT) products. Solutions span the development life cycle from concept to production and help device makers and technology suppliers create compelling differentiated products with faster time-to-market.  Intrinsyc's Open-Q(TM) and Open-X(TM) System on Modules incorporate the industry's most advanced processor technology and help OEMs to rapidly bring industry leading products, with rich functionality and high performance, to market. Intrinsyc is publicly traded (TSX:ITC) (OTC:ISYRF) and is headquartered in Vancouver, BC, Canada.

For more information, please contact:

Rachele Webb
Senior Marketing Communications Coordinator
Intrinsyc Technologies Corporation
Email: rwebb@intrinsyc.com

Intrinsyc, Open-X and their respective logos are trademarks, registered and otherwise, of Intrinsyc Technologies Corporation in Canada, European Union, Taiwan, United States of America and other jurisdictions




This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Intrinsyc Technologies Corporation via Globenewswire

Om

GlobeNewswire



Följ GlobeNewswire

Abonnera på våra pressmeddelanden.

Senaste pressmeddelandena från GlobeNewswire

Arcoma AB: Investerarmöten våren 201915.2.2019 08:46:00Pressmeddelande

15 februari 2019 PRESSRELEASE Arcoma har som ambition att fortsätta öka sitt aktieägarfokus och kontinuerligt förbättra kommunikationen med aktieägare. Under våren 2019 kommer Arcoma medverka på flertalet investerarmöten där aktuella händelser och aktiviteter presenteras. Här ges en ökad inblick i bolagets vision och strategier samt en möjlighet till att ställa frågor till bolagets ledning. SvD Börsplus Temadag "Dubblare" Dag, tid och plats: 5 mars, kl. 13.00, GT 30, Grev Turegatan 30, Stockholm Stockholm Corporate Finance Life Science event Dag, tid och plats: 14 mars, kl. 07.30, Berns, Kammarsalen, Stockholm Redeyes Medtech & Diagnostics event Dag, tid och plats: 14:e maj, Redeye, Mäster Samuelsgatan 42, Stockholm För ytterligare information, vänligen kontakta: Arcomas VD Jesper Söderqvist, Telefon: +46 470 70 69 81, E-mail: jesper.soderqvist at arcoma.se Om Arcoma Arcoma, med lång erfarenhet av branschen, är en ledande leverantör av integrerade digitala röntgensystem med hög kvalite

Corline Biomedical AB: Första patient doserad med Renaparin®15.2.2019 08:42:00Pressmeddelande

Corline Biomedical AB ("Corline" eller "Bolaget") meddelar idag att man inkluderat första patienten i fas 1-studien RENAPAIR 01. Patienten inkluderades vid transplantationsavdelningen på Uppsala Akademiska sjukhus. Renaparin® är en produkt under utveckling för att förbättra njurtransplantation. I Corlines studie RENAPAIR 01 utvärderas produkten med avseende på tolerabilitet och säkerhet. Studien öppnades för patientrekrytering i slutet av 2018 och första patient är nu doserad och inkluderad i studien. Totalt skall 18 patienter rekryteras och när de 4 första patienterna är utvärderade i Uppsala, öppnas också Karolinska Universitetssjukhuset i Huddinge för rekrytering till studien. Henrik Nittmar, VD i Corline Biomedical AB, kommenterar "Det händer mycket i Corline för tillfället och alla arbetar hårt för att målbilden i bolaget skall uppfyllas. Det gäller såväl vår interna organisation som våra externa samarbetspartners. Därför är det extra roligt när vi når avgörande milstolpar i utvec

Corline Biomedical AB: Rekryterar Lars Olsson som Head of CMC14.2.2019 12:44:00Pressmeddelande

Corline Biomedical AB ("Corline" eller "Bolaget") meddelar idag att man rekryterat Lars Olsson till den nyinrättade tjänsten som Head of CMC (Chemistry, Manufacturing & Control). Lars Olsson hade tidigare samma tjänst hos Wilson Therapeutics AB, som under 2018 förvärvades av amerikanska Alexion. Lars Olsson kommer att ansvara för Corlines samtliga aktiviteter inom tillverkning och kontroll relaterat till bolagets läkemedelsprodukter, med särskilt fokus på Renaparin® inför kommande fas 2- och fas 3-utveckling. I slutet av 2018 meddelade Corline att patientrekryteringen startar i bolagets fas 1-studie RENAPAIR 01, där produkten Renaparin®, som är under utveckling för att förbättra utfallet av njurtransplantation, utvärderas med avseende på tolerabilitet och säkerhet. Därmed tog en ny utvecklingsfas vid i bolaget i vilken alltmer resurser fokuseras på att förbereda den fortsatta kliniska utvecklingen av produkten genom fas 2 och fas 3 i syfte att slutligen kunna registrera produkten för k

Arcoma AB: Canon och Arcoma tecknar distributörsavtal för Turkiet14.2.2019 10:38:00Pressmeddelande

14 februari 2019 Canon Medical Systems i Turkiet och Arcoma har tecknat ett distributörsavtal som gör att Canon kommer att kunna sälja Arcomas produkter i Turkiet från och med den 15 februari 2019. Canon är sedan tidigare återförsäljare för Arcomas produkter i Nordamerika och utvalda länder i Europa. Detta samarbete utökas nu till Turkiet som är det första land i Canons Asien organisation att välja Arcoma som en formell partner. "Att vi stärker och formaliserar samarbetet med Canon även i Turkiet är ännu ett erkännande av Arcoma som leverantör av högkvalitativa röntgensystem. Canon i Turkiet förbereder ett flertal större upphandlingar till sjukhus där Arcomas lösningar ingår. Avtal som detta ingår i Arcomas strategi att utöka med nya försäljningskanaler och att expandera till nya länder för att skapa framtida tillväxt." kommenterar Arcomas VD, Jesper Söderqvist. För ytterligare information, vänligen kontakta: Arcomas VD Jesper Söderqvist, Telefon: +46 470 70 69 81, E-mail: jesper.soder

Karolinska Development's portfolio company OssDsign raises SEK 64m and aims for listing on Nasdaq First North12.2.2019 09:00:00Pressmeddelande

STOCKHOLM, February 12, 2019. Karolinska Development's portfolio company OssDsign announces today the closing of a private placement of SEK 64 million. Swedish private investors and the French investment management company Alto Invest have taken part in the private placement. OssDsign will now begin the process towards a listing on Nasdaq First North in 2019. The proceeds from the private placement will be used for continued sales expansion in Europe and the US of OssDsign regenerative implant solutions for improved healing of bone defects. Moreover, funds will be used for entering new markets, primarily preparing for market introduction in Japan where the company in parallel to the regulatory process will initiate pre marketing activities. With ethical committee approval already in place, leading surgeons in Japan can start building experience with the OssDsign technology prior to regulatory approval and launch. OssDsign prepares for a listing on Nasdaq Stockholm First North in 2019.

Karolinska Development's portfolio company OssDsign raises SEK 64m and aims for listing on Nasdaq First North12.2.2019 09:00:00Pressmeddelande

STOCKHOLM, February 12, 2019. Karolinska Development's portfolio company OssDsign announces today the closing of a private placement of SEK 64 million. Swedish private investors and the French investment management company Alto Invest have taken part in the private placement. OssDsign will now begin the process towards a listing on Nasdaq First North in 2019. The proceeds from the private placement will be used for continued sales expansion in Europe and the US of OssDsign regenerative implant solutions for improved healing of bone defects. Moreover, funds will be used for entering new markets, primarily preparing for market introduction in Japan where the company in parallel to the regulatory process will initiate pre marketing activities. With ethical committee approval already in place, leading surgeons in Japan can start building experience with the OssDsign technology prior to regulatory approval and launch. OssDsign prepares for a listing on Nasdaq Stockholm First North in 2019.

I vårt pressrum kan du läsa de senaste pressmeddelandena, få tillgång till pressmaterial och hitta kontaktinformation.

Besök vårt pressrum